The FDA generally protects company data, including what manufacturing facility a drug is created in, for anxiety of working afoul of trade secret guidelines. In 2011, the FDA explained it identified 1,900 instances all through an inspection of the Cetero Study facility where lab professionals that supposedly conducted sure checks weren't during the